See related Isentress film-coated tab information |
|
Manufacturer |
MSD |
Distributor |
Zuellig |
Contents |
Raltegravir |
Indications |
In combination w/ other antiretrovirals for the treatment of HIV-1 infection.
Click to view Isentress detailed prescribing infomation |
Dosage |
400 mg bid.
Click to view Isentress detailed prescribing infomation |
Overdosage |
View Isentress overdosage for action to be taken in the event of an overdose. |
Administration |
May be taken with or without food |
Contraindications |
Hypersensitivity.
Click to view Isentress detailed prescribing infomation |
Special Precautions |
Inflammatory response to indolent or residual opportunistic infections may develop during the initial phase of treatment. Pregnancy & lactation. Childn <16 yr.
Click to view Isentress detailed prescribing infomation |
Adverse Drug Reactions |
Diarrhea, nausea, headache, nasopharyngitis, asthenia, fatigue, upper resp tract infection, bronchitis, pyrexia, vomiting.
View ADR Monitoring Form |
Side Effects |
View Isentress side effects |
Drug Interactions |
Strong inducers of uridine diphosphate glucuronosyltransferase (UGT) 1A1 eg rifampin.
View more drug interactions with Isentress |
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
Storage |
View Isentress storage conditions for details to ensure optimal shelf-life. |
Description |
View Isentress description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View Isentress mechanism of action for pharmacodynamics and pharmacokinetics details. |
Presentation/Packing |
Form |
Packing |
Photo |
Isentress film-coated tablet |
Isentress 400 mg x 60's |
 |
|
|
Manufacturer: |
MSD |
Distributor: |
Zuellig |
|
 |
|
|